Table 5.
Effects of intervention with placebo and PVE on biochemical parameters in obese subjects (Data are shown as means ± standard deviation)
| Placebo (n = 58) | p Value | PVE (n = 56) | p Value | |||
|---|---|---|---|---|---|---|
| Baseline | 35 Days | Baseline | 35 Days | |||
| Total serum protein (g/L) | 70.1 ± 3.4 | 71.2 ± 3.6 | >.05 | 71.1 ± 3.9 | 71.1 ± 3.7 | >.05 |
| Serum albumin (g/L) | 43.8 ± 2.6 | 44.7 ± 2.8 | >.05 | 44.6 ± 2.3 | 44.5 ± 2.2 | >.05 |
| Aspartate aminotransferase (U/L) | 26.7 ± 9.9 | 27.7 ± 8.8 | >.05 | 27.5 ± 7.2 | 26.3 ± 6.4 | >.05 |
| Alanine aminotransferase (U/L) | 24.3 ± 7.4 | 25.6 ± 5.8 | >.05 | 24.9 ± 6.7 | 26.2 ± 5.7 | >.05 |
| Blood glucose (mmol/L) | 4.98 ± 0.51 | 5.08 ± 0.50 | >.05 | 4.99 ± 0.60 | 5.02 ± 0.58 | >.05 |
| Blood urea nitrogen (mmol/L) | 5.26 ± 1.49 | 5.44 ± 1.14 | >.05 | 5.28 ± 1.18 | 5.26 ± 1.29 | >.05 |
| Uric acid (μmol/L) | 309.8 ± 81.2 | 307.9 ± 64.8 | >.05 | 317.7 ± 65.5 | 312.6 ± 58.8 | >.05 |
| Creatinine (μmol/L) | 77.1 ± 14.2 | 75.7 ± 13.4 | >.05 | 80.7 ± 16.6 | 80.9 ± 15.8 | >.05 |